5 completed, 3 recruiting, 1 active not recruiting, 1 withdrawn. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Recruiting 3, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Magnetic Resonance Imaging: new trials by email Literature Review of Magnetic Resonance Imaging trials Research Report on Magnetic Resonance Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brain Blood Vessel Responses to Changes in Blood Flow MRI, Prazosin, Placebo - Magnetic Resonance Imaging, Cerebrovascular Circulation | Phase 2 | Recruiting | University of Wisconsin, Madison | 36 | 2026-02-26 | 2026-09-15 |
| Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort MRI, Prazosin, Placebo - Magnetic Resonance Imaging, Cerebrovascular Circulation | Phase 2 | Recruiting | University of Wisconsin, Madison | 36 | 2025-12-17 | 2026-07-06 |
| Effect of Nutritional Ketosis on Alcohol Metabolism Ketone Supplement, Control Diet, Ketogenic diet - Ketoses, Metabolic, Ketogenic Dieting | Phase 2 / Phase 3 | Active not recruiting | University of Pennsylvania | 23 | 2024-02-29 | 2026-04-07 |
| Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients Polysaccharide superparamagnetic iron oxide injection - Diabetes, Magnetic Resonance Imaging | Phase 1 / Phase 2 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 12 | 2021-11-06 | 2023-09-29 |
| Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis Methylprednisolone succinate, Normal saline - Multiple Sclerosis, Relapsing-Remitting, Magnetic Resonance Imaging | Phase 2 | Completed | Mazandaran University of Medical Sciences | 102 | 2021-05-22 | 2025-07-15 |
| Intra Articular Injection of Botulinum Toxin Versus Corticoids in Gonarthrosis Botulinum Toxin Type A 100U, Botulinum Toxin Type A 200U, Triamcinolone Hexacetonide Inj Susp 20 MG/ML - Joint Diseases, Knee | Phase 2 | Withdrawn | Lille Catholic University | 2019-09-01 | 2025-09-10 | |
| The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma IOP Injection (MPB-1523) - Magnetic Resonance Imaging | Phase 2 | Completed | MegaPro Biomedical Co. Ltd. | 52 | 2018-11-22 | 2021-10-22 |
| Ketamine Alcohol (in Treatment-Resistant Depression) Ketamine - Magnetic Resonance Imaging, Major Depression | Phase 2 | Recruiting | Mark Niciu | 60 | 2014-04-23 | 2026-05-01 |
| Axillary Plexus Block in a High Resolution MRI Active Comparator: Arm 1: catheter injection, Active Comparator: Arm 2: transarterial injection, Active Comparator: Arm 3: catheter and transarterial injection - Nerve Block, Magnetic Resonance Imaging | Phase 2 | Completed | Diakonhjemmet Hospital | 45 | 2009-01-01 | 2014-02-13 |
| Myocardial Perfusion MRI Gadobutrol (Gadavist,Gadovist, BAY86-4875) - Myocardial Perfusion Imaging, Magnetic Resonance Imaging | Phase 2 | Completed | Bayer | 232 | 2004-03-01 | 2014-05-22 |
Alcohol Drinking (1) · Alcoholic Intoxication (1) · Alcoholism (1) · Carcinoma, Hepatocellular (1) · Depressive Disorder, Major (1) · Diabetes Mellitus (1) · Joint Diseases (1) · Ketosis (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Osteoarthritis (1)
Alcohol-Related Disorders (2) · Chemically-Induced Disorders (2) · Mental Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Substance-Related Disorders (2) · Acid-Base Imbalance (1) · Acidosis (1) · Adenocarcinoma (1) · Arthritis (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Behavior (1) · Carcinoma (1) · Demyelinating Autoimmune Diseases, CNS (1)
Prazosin (2) · Botulinum Toxins, Type A (1) · Diet, Ketogenic (1) · Ethanol (1) · Exercise (1) · Ketamine (1) · Methylprednisolone Hemisuccinate (1) · Saline Solution (1) · gadobutrol (1)
University of Wisconsin, Madison (2) · Bayer (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Diakonhjemmet Hospital (1) · Lille Catholic University (1) · Mark Niciu (1) · Mazandaran University of Medical Sciences (1) · MegaPro Biomedical Co. Ltd. (1) · University of Pennsylvania (1)
United States (4) · Austria (1) · China (1) · France (1) · Germany (1) · Iran (1) · Norway (1) · Poland (1) · Switzerland (1) · Taiwan (1)
Jill Barnes, PhD (2) · Chien-Hung Chen, MD (1) · Corinde Wiers, Ph.D. (1) · David Wang, MD (1) · Henry Kranzler, MD (1) · Hichem Khenioui, MD (1) · Kyle Kampman, MD (1) · Mark J Niciu, M.D. Ph.D. (1) · Seyed Mohammad Baghbanian, Dr. (1) · Trygve TK Kjelstrup, MD (1)
1RF1NS117746-01 (1), 2005 (1), R00AA024142 (1), R21AA031088 (1)